Crossmark

Phase II Non-Randomised Trial of Oral Chlorophyllin in Haemorrhagic Cystitis from Radiation Therapy (CLARITY Trial): clinical and quality-of-life outcomes with exploratory proteomics

Crossref DOI link: https://doi.org/10.1038/s41598-026-64669-4

Published Online: 2026-08-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Prakash, Gagan https://orcid.org/0000-0003-1722-4337
Gota, Vikram

Sharma, Deepak

Chopra, Supriya

Pal, Mahendra

Arora, Amandeep

Nagarajan, Ramya

Misra, Ankit

Bakshi, Ganesh

Murthy, Vedang

Maitre, Priyamvada

Gurram, Lavanya

Mittal, Prachi

Patwardhan, Raghavendra S.

Checker, Rahul

Joshi, Mahendra

Madki, Shivkumar

Gupta, Saurabh

Kumar, Sharath

Dethe, Shraddha Bonkar

Gawad, Priyal

Ghadge, Sanjana

Menon, Santosh

Ghanty, Tapan

Kannan, Sadhana

Badwe, Rajendra

Chaturvedi, Pankaj

Gupta, Sudeep

Sandur, Santosh K.
Funding

Funding for this research was provided by:

Department of Atomic Energy, Government of India
License Information

Text and Data Mining valid from 2026-08-10

Accepted Manuscript valid from 2026-08-10
More Information

Article History

Received: 26 January 2026

Accepted: 27 July 2026

First Online: 10 August 2026

Ethics

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below